Description And Band Names
Tofacitinib is a medication classified as a Janus kinase (JAK) inhibitor. It works by targeting intracellular enzymes called JAKs, which play a role in transmitting signals involved in immune cell function and other cellular processes. By inhibiting these enzymes, tofacitinib helps regulate the immune system’s response, particularly in conditions like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis.
| Brand Name | Dosage From | Strength | Manufacturer |
| Xeljanz | Tablet | 5 mg | Pfizer |
| Xeljanz XR | Tablet (Extended Release) | 11 mg | Pfizer |
| Tofacent | Tablet | 5 mg | Incepta Pharmaceuticals Ltd |
| Tofacent XR | Tablet (Extended Release) | 11 mg | Incepta Pharmaceuticals Ltd |
| Tofacinix | Tablet | 5 mg | Beacon Pharmaceuticals PLC |
| Tofacinix XR | Tablet (Extended Release) | 11 mg | Beacon Pharmaceuticals PLC |
| Tocit | Tablet | 5 mg | Drug International Ltd |
| Tocit XR | Tablet (Extended Release) | 11 mg | Drug International Ltd |
| Tofaxen | Tablet | 5 mg | Everest Pharmaceuticals Ltd |